Introduction
In 1973, a clinicopathological entity called 'Immunoblastic lymphadenopathy' was described (Lukes and Tindle, 1973) . A year later, 15 similar cases called angioimmunoblastic lymphadenopathy with dysproteinemia' (AILD) were published (Frizzera, Moran and Rappaport, 1974) . AILD is a disease which manifests itself in most patients by an aggressive course although about onethird of the patients survive more than two years (Cullen et al., 1979) . AILD has been described in association with autoimmune disorders, drugs and other conditions. However, it has not been reported (Kyle et al., 1971) preceded by benign hyperglobulinaemic purpura of Waldenstrom (BHPW) .
A patient is reported in whom the first presentation was with BHPW and Coombs' positive haemolytic anaemia. The diagnosis of AILD was established later by a lymph node biopsy. 
Case report
A 76-year-old woman of Yemenite Jewish origin was first admitted to our medical centre in 1964 at the age of 59 years because of a purpuric rash of her lower limbs and marked weakness. On examination she had hepatosplenomegaly (liver and spleen palpable 3 cm and 4 cm respectively below the costal margin), enlarged axillary lymph nodes and a purpuric rash on both feet and calves. Laboratory tests revealed a haemoglobin level of 6-1 g/dl, a platelet count of 140 x 109/1, a reticulocyte count of 10%, a white blood cell count of 2-8 x 109/1 with 79 % neutrophils, 2 % eosinophils, 4 (Fig. 1) . A truly striking feature, particularly with the reticulin stain, was the tremendous proliferation with arborization of postcapillary venules observed throughout the section (Fig. 2) (Waldenstrom, 1943) and the finding in the majority of patients of circulating immune complexes (Kyle et al., 1971) . In about half of the patients BHPW is primary whereas in the rest it precedes by several years the development of chronic lymphocytic leukaemia, Sjogren's syndrome, keratoconjuctivitis sicca, systemic lupus erythematosus and other collagen diseases (Kyle et al., 1971 (Cullen et al., 1979) . The use of cytotoxic agents has been advocated by some with good results as the initial therapy (Cullen et al., 1979) but the enhancement of severe infections may contraindicate their use (Lukes and Tindle, 1975 (Pruzanski, 1980 (Lukes and Tindle, 1975) whilst others have stressed the presence of a T cell defect (Frizzera et al., 1975) . Thus, immunological studies (Kreisler et al., 1977) showed either a high or a normal percentage of B cells (Watanabe, 1977) 
